Stocktoria
Voyager Acquisition Corp./Cayman Islands VACH
Voyager Acquisition Corp./Cayman Islands (VACH) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend.
How it ranks in Manufacturing · percentile among 2036 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.004 |
| Retained earnings / assets | -0.049 |
| EBIT / assets | -0.007 |
| Equity / liabilities | -0.985 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| VACH | Voyager Acquisition Corp./Cayman Islands | 2/9 | -1.26 | 170.1 | — |
| AMGN | AMGEN INC | 6/9 | 0.14 | 25.1 | +10% |
| GILD | GILEAD SCIENCES, INC. | 7/9 | 3.28 | 18.7 | +2.4% |
| BIIB | BIOGEN INC. | 4/9 | — | 24.7 | +2.2% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 5/9 | 6.21 | 35.4 | +21.4% |
| EXEL | EXELIXIS, INC. | 6/9 | 7.69 | 17.6 | +7% |
| QGEN | QIAGEN N.V. | 7/9 | 5.06 | 19.1 | +5.7% |
About Voyager Acquisition Corp./Cayman Islands
Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. Voyager Acquisition Corp. was incorporated in 2023 and is based in Brooklyn, New York.
FAQ
Is VACH financially healthy?
Voyager Acquisition Corp./Cayman Islands's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does VACH pay a dividend?
No, Voyager Acquisition Corp./Cayman Islands does not currently pay a dividend.
What is VACH's P/E ratio?
Voyager Acquisition Corp./Cayman Islands's trailing price-to-earnings (P/E) ratio is about 170.1×, based on its latest annual earnings.
Is VACH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Voyager Acquisition Corp./Cayman Islands: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone, a P/E of about 170.1×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.